// App-Quantinova.ai

: Treatment of dyspnea in do-not-intubate (DNI) patients: is NIV a sensible option?

Researchers

Presenter

  • Giulia Spoletini

Principal Investigators

  • Lara Pisani

  • Najia Idrees

  • Trung Tien

  • Chiara Mega

  • Alia Khoja

  • Marco Mantero

  • Francesco Blasi

  • Stefano Nava

  • Nicholas Hill

  • Ami Chi

Medical Centers

  • Respiratory Medicine, St Jame- University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • Department of Clinical, Integrated and Experimental Medicine (DIMES), Respiratory and Critical Care Unit, Ospedale Sant’Orsola Malpighi, Alma Mater University, Bologna, Italy

  • Pulmonary, Critical Care, Sleep Medicine Division, Tufts Medical Center, Boston, United States of America

  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, IRCCS Fondazione Ospedale Maggiore Policlinico Ca’ Granda, Milano, Italy

  • Department of Anaesthesia and Intensive Care, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

  • Department of Internal Medicine, George Washington University, Washington DC, United States of America

  • Pulmonary and Crtical Care Medicine, Winchester Hospital, Winchester, United States of America

Locations

  • United Kingdom

  • Italy

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Dyspnea

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved